Acylated insulin compound
The presently described compounds relate to the treatment of diabetes and/or hyperglycemia. More particularly, the described compounds relate to acylated insulin compounds that lower blood glucose, pharmaceutical compositions containing such compounds, therapeutic uses of such compounds, and an intermediate compound used to make the acylated insulin compounds.
Eli Lilly and Company
A C A A A
A61K C07K A61K A61K A61P
inventional inventional additional inventional inventional
Francisco Alcides Wen Adam Robert
Valenzuela Liu Mezo